دورية أكاديمية
Vitamin E in the management of pancreatic cancer: A scoping review.
| العنوان: | Vitamin E in the management of pancreatic cancer: A scoping review. |
|---|---|
| المؤلفون: | Ekeuku SO; Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia., Etim EP; Faculty of Applied Sciences, UCSI University, Kuala Lumpur 56000, Malaysia., Pang KL; Newcastle University Medicine Malaysia, Iskandar Puteri 79200, Johor, Malaysia., Chin KY; Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.; State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China., Mai CW; State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.; Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur 56000, Malaysia. mai.chunwai@gmail.com. |
| المصدر: | World journal of gastrointestinal oncology [World J Gastrointest Oncol] 2023 Jun 15; Vol. 15 (6), pp. 943-958. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Baishideng Publishing Group Country of Publication: China NLM ID: 101532470 Publication Model: Print Cited Medium: Print ISSN: 1948-5204 (Print) NLM ISO Abbreviation: World J Gastrointest Oncol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: 2014- : Pleasanton, CA : Baishideng Publishing Group Original Publication: Beijing, China : Baishideng |
| مستخلص: | Pancreatic cancer is the leading cause of cancer mortality worldwide. Research investigating effective management strategies for pancreatic cancer is ongoing. Vitamin E, consisting of both tocopherol and tocotrienol, has demonstrated debatable effects on pancreatic cancer cells. Therefore, this scoping review aims to summarize the effects of vitamin E on pancreatic cancer. In October 2022, a literature search was conducted using PubMed and Scopus since their inception. Original studies on the effects of vitamin E on pancreatic cancer, including cell cultures, animal models and human clinical trials, were considered for this review. The literature search found 75 articles on this topic, but only 24 articles met the inclusion criteria. The available evidence showed that vitamin E modulated proliferation, cell death, angiogenesis, metastasis and inflammation in pancreatic cancer cells. However, the safety and bioavailability concerns remain to be answered with more extensive preclinical and clinical studies. More in-depth analysis is necessary to investigate further the role of vitamin E in the management of pancreatic cancers. Competing Interests: Conflict-of-interest statement: All the authors report having no relevant conflicts of interest for this article. (©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.) |
| References: | Oncogene. 2021 Feb;40(8):1440-1457. (PMID: 33420372) World J Oncol. 2019 Feb;10(1):10-27. (PMID: 30834048) Mol Cancer Ther. 2011 Dec;10(12):2363-72. (PMID: 21971120) Gastroenterology. 2022 Aug;163(2):386-402.e1. (PMID: 35398344) Free Radic Biol Med. 2011 Sep 15;51(6):1164-74. (PMID: 21723941) J Lipid Res. 2007 May;48(5):1090-8. (PMID: 17284776) Cancer Res. 2010 Nov 1;70(21):8695-705. (PMID: 20864511) Free Radic Biol Med. 1992;13(1):55-74. (PMID: 1628854) Phytother Res. 2018 Jun;32(6):1108-1118. (PMID: 29464796) Carcinogenesis. 2013 Apr;34(4):858-63. (PMID: 23302291) Nat Immunol. 2020 Oct;21(10):1152-1159. (PMID: 32807942) Ann Oncol. 2017 Oct 01;28(10):2429-2435. (PMID: 28961832) Biomedicines. 2021 Jul 25;9(8):. (PMID: 34440093) Nat Rev Gastroenterol Hepatol. 2021 Nov;18(11):804-823. (PMID: 34331036) Pancreatology. 2005;5(4-5):403-9. (PMID: 15985764) J Clin Exp Cardiolog. 2016 Apr;7(4):. (PMID: 27493840) J Pharm Pharmacol. 2001 Jan;53(1):67-71. (PMID: 11206194) Biochem Biophys Res Commun. 2014 Oct 24;453(3):606-11. (PMID: 25285637) Trends Cell Biol. 2019 Mar;29(3):212-226. (PMID: 30594349) Nanomedicine (Lond). 2021 Feb;16(5):373-389. (PMID: 33543651) J Exp Clin Cancer Res. 2019 Apr 15;38(1):162. (PMID: 30987642) J Am Oil Chem Soc. 2017 Sep;94(9):1209-1217. (PMID: 33518766) EBioMedicine. 2015 Nov 14;2(12):1987-95. (PMID: 26844278) Lab Invest. 2021 Feb;101(2):204-217. (PMID: 33037322) Microsyst Nanoeng. 2022 Mar 31;8:36. (PMID: 35450328) Scand J Gastroenterol. 2004 Sep;39(9):882-5. (PMID: 15513387) Pharmacology. 2009;83(3):157-63. (PMID: 19142032) Nature. 2022 Aug;608(7924):795-802. (PMID: 35978189) Open Med. 2009;3(3):e123-30. (PMID: 21603045) Semin Oncol. 2021 Feb;48(1):10-18. (PMID: 33676749) Cold Spring Harb Perspect Med. 2023 Feb 1;13(2):. (PMID: 35667708) PLoS One. 2013;8(2):e52526. (PMID: 23393547) Heliyon. 2019 Oct 12;5(10):e02645. (PMID: 31667433) Front Pharmacol. 2022 Jul 06;13:903210. (PMID: 35873548) Cancers (Basel). 2022 Jul 29;14(15):. (PMID: 35954379) Nat Med. 2019 Apr;25(4):620-627. (PMID: 30833748) Pharmaceutics. 2020 Aug 16;12(8):. (PMID: 32824299) Curr Med Chem. 2018;25(22):2585-2594. (PMID: 28137215) Mini Rev Med Chem. 2021;21(1):10-22. (PMID: 32767937) BMC Complement Altern Med. 2019 Sep 14;19(1):257. (PMID: 31521140) Apoptosis. 2018 Jun;23(5-6):343-355. (PMID: 29740790) Cancer Metastasis Rev. 2021 Sep;40(3):691-720. (PMID: 34453639) Cancer Prev Res (Phila). 2013 Oct;6(10):1074-83. (PMID: 23963802) Cancer Lett. 2022 Sep 1;543:215794. (PMID: 35718268) Onco Targets Ther. 2013 Nov 05;6:1573-87. (PMID: 24235843) J Basic Clin Pharm. 2016 Mar;7(2):27-31. (PMID: 27057123) Oncotarget. 2017 May 9;8(19):31554-31567. (PMID: 28404939) Cancers (Basel). 2021 Sep 07;13(18):. (PMID: 34572737) Dig Dis Sci. 2001 Dec;46(12):2768-72. (PMID: 11768272) Pancreas. 2010 Jul;39(5):662-8. (PMID: 20562578) Front Oncol. 2018 Jul 02;8:248. (PMID: 30013950) Cancers (Basel). 2021 Mar 02;13(5):. (PMID: 33801191) Pancreas. 2009 May;38(4):e124-36. (PMID: 19346993) Cancers (Basel). 2018 Mar 18;10(3):. (PMID: 29562636) BMC Cancer. 2018 May 16;18(1):564. (PMID: 29769046) Cancer Cell Int. 2019 Jul 22;19:189. (PMID: 31367187) Mol Cancer Res. 2021 Jan;19(1):25-37. (PMID: 33004622) Int J Nanomedicine. 2020 Dec 08;15:9961-9974. (PMID: 33324057) Ann Transl Med. 2019 Jul;7(Suppl 3):S153. (PMID: 31576360) Cell Death Discov. 2022 Sep 2;8(1):378. (PMID: 36055991) PLoS One. 2017 Jan 20;12(1):e0170551. (PMID: 28107519) Genes Nutr. 2012 Jan;7(1):83-9. (PMID: 21842182) Cancers (Basel). 2020 Jul 11;12(7):. (PMID: 32664564) Biomedicines. 2020 Sep 07;8(9):. (PMID: 32906721) Stem Cell Investig. 2018 Mar 12;5:5. (PMID: 29682512) Cancer Chemother Pharmacol. 2016 Jul;78(1):157-65. (PMID: 27278668) World J Gastroenterol. 2021 Jul 21;27(27):4298-4321. (PMID: 34366606) Nat Commun. 2022 Apr 21;13(1):2169. (PMID: 35449156) BMC Cancer. 2019 Aug 7;19(1):781. (PMID: 31391085) Ann Intern Med. 2005 Jan 4;142(1):37-46. (PMID: 15537682) J Clin Med. 2019 Jul 24;8(8):. (PMID: 31344926) Expert Opin Drug Discov. 2019 Feb;14(2):127-142. (PMID: 30657339) Nat Commun. 2017 Oct 23;8(1):1090. (PMID: 29061961) Molecules. 2020 Sep 12;25(18):. (PMID: 32932573) Biochem Biophys Res Commun. 2010 Jun 25;397(2):214-9. (PMID: 20493172) Nat Rev Clin Oncol. 2021 May;18(5):261-279. (PMID: 33469195) Nat Commun. 2020 Jun 4;11(1):2817. (PMID: 32499547) Adv Nutr. 2017 Nov 15;8(6):850-867. (PMID: 29141970) Cancer Discov. 2022 Jan;12(1):31-46. (PMID: 35022204) Eur J Med Chem. 2014 Apr 22;77:378-87. (PMID: 24675137) J Am Diet Assoc. 2000 Jun;100(6):637-40. (PMID: 10863565) J Nutr Biochem. 2015 Aug;26(8):797-807. (PMID: 25997867) Int J Mol Sci. 2019 Jan 16;20(2):. (PMID: 30654580) World J Gastroenterol. 2022 May 14;28(18):1934-1945. (PMID: 35664961) Front Pharmacol. 2018 Nov 26;9:1358. (PMID: 30534071) Nutrients. 2020 Jan 19;12(1):. (PMID: 31963885) Prostaglandins Leukot Essent Fatty Acids. 2001 Sep;65(3):165-71. (PMID: 11728167) Lipids Health Dis. 2018 Apr 2;17(1):62. (PMID: 29606130) J Surg Res. 2000 Jan;88(1):23-5. (PMID: 10644462) Front Physiol. 2018 Apr 04;9:335. (PMID: 29670543) |
| فهرسة مساهمة: | Keywords: Anti-cancer treatment; Pancreatic cancer; Scoping review; Tocopherol; Tocotrienol; Vitamin E |
| تواريخ الأحداث: | Date Created: 20230630 Latest Revision: 20230703 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC10302993 |
| DOI: | 10.4251/wjgo.v15.i6.943 |
| PMID: | 37389119 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1948-5204 |
|---|---|
| DOI: | 10.4251/wjgo.v15.i6.943 |